Geratherm Medical (GME) Stock Overview
Operates as a medical technology company in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
GME Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Geratherm Medical AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.75 |
| 52 Week High | €7.88 |
| 52 Week Low | €2.48 |
| Beta | 0.55 |
| 1 Month Change | -6.46% |
| 3 Month Change | -18.88% |
| 1 Year Change | -23.18% |
| 3 Year Change | -65.45% |
| 5 Year Change | -78.17% |
| Change since IPO | -71.65% |
Recent News & Updates
Not Many Are Piling Into Geratherm Medical AG (ETR:GME) Stock Yet As It Plummets 26%
Nov 29
A Look At The Fair Value Of Geratherm Medical AG (ETR:GME)
Nov 06Recent updates
Not Many Are Piling Into Geratherm Medical AG (ETR:GME) Stock Yet As It Plummets 26%
Nov 29A Look At The Fair Value Of Geratherm Medical AG (ETR:GME)
Nov 06Geratherm Medical AG's (ETR:GME) Shares Leap 32% Yet They're Still Not Telling The Full Story
Oct 02Geratherm Medical's (ETR:GME) Shareholders May Want To Dig Deeper Than Statutory Profit
Sep 05Geratherm Medical AG (ETR:GME) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
Dec 13Investors Don't See Light At End Of Geratherm Medical AG's (ETR:GME) Tunnel And Push Stock Down 26%
Oct 16The Market Lifts Geratherm Medical AG (ETR:GME) Shares 28% But It Can Do More
Aug 21We Think Geratherm Medical's (ETR:GME) Solid Earnings Are Understated
Jun 27Geratherm Medical (ETR:GME) Is Reducing Its Dividend To €0.12
Apr 10Is Geratherm Medical (ETR:GME) A Risky Investment?
Mar 02Geratherm Medical (ETR:GME) Has Some Way To Go To Become A Multi-Bagger
May 08Is Geratherm Medical AG's (ETR:GME) 2.1% Dividend Sustainable?
Apr 19Is Geratherm Medical (ETR:GME) A Risky Investment?
Mar 01Returns On Capital Tell Us A Lot About Geratherm Medical (ETR:GME)
Jan 22
Consider This Before Buying Geratherm Medical AG (ETR:GME) For The 2.3% Dividend
Jan 04Update: Geratherm Medical (ETR:GME) Stock Gained 22% In The Last Year
Dec 17We Think Geratherm Medical (ETR:GME) Can Stay On Top Of Its Debt
Nov 29Shareholder Returns
| GME | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -1.4% | -2.0% | 0.3% |
| 1Y | -23.2% | -29.0% | 5.6% |
Return vs Industry: GME exceeded the German Medical Equipment industry which returned -29% over the past year.
Return vs Market: GME underperformed the German Market which returned 5.6% over the past year.
Price Volatility
| GME volatility | |
|---|---|
| GME Average Weekly Movement | 7.6% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in DE Market | 13.4% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: GME has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: GME's weekly volatility has decreased from 14% to 8% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 144 | Christian Frick | www.geratherm.com |
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors.
Geratherm Medical AG Fundamentals Summary
| GME fundamental statistics | |
|---|---|
| Market cap | €14.79m |
| Earnings (TTM) | €1.75m |
| Revenue (TTM) | €14.29m |
Is GME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GME income statement (TTM) | |
|---|---|
| Revenue | €14.29m |
| Cost of Revenue | €8.33m |
| Gross Profit | €5.96m |
| Other Expenses | €4.21m |
| Earnings | €1.75m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 41.70% |
| Net Profit Margin | 12.27% |
| Debt/Equity Ratio | 12.7% |
How did GME perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/15 11:16 |
| End of Day Share Price | 2026/02/13 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Geratherm Medical AG is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Oliver Wojahn | mwb research AG |
| Klaus Schlote | Solventis Wertpapierhandelsbank GmbH |